Dendrimer-based contrast agents for molecular imaging

被引:91
作者
Longmire, Michelle [1 ]
Choyke, Peter L. [1 ]
Kobayashi, Hisataka [1 ]
机构
[1] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA
关键词
dendrimer; contrast agent; molecular imaging; nanomedicine; magnetic resonance imaging; optical imaging; radionuclide imaging; multiple modalities;
D O I
10.2174/156802608785849021
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The extensive adaptability of dendrimer-based contrast agents is ideal for the molecular imaging of organs and other target-specific locations. The ability of literally atom-by-atom modification on cores, interiors, and surface groups, permits the rational manipulation of dendrimer-based agents in order to optimize their physical characteristics, biodistribution, receptor-mediated targeting, and controlled release of the payload. Such modifications enable agents to localize preferentially to areas or organs of interest for facilitating target-specific imaging as well as assume excretion pathways that do not interfere with desired applications. Recent innovations in dendrimer research have increased agent directibility and new synthetic chemistry approaches have increased efficiency of production as well as led to the creation of novel dendrimer-based contrast agents. In addition, by taking advantage of the numerous attachment sites available on the surface of a single dendrimer molecule, new synthetic chemistry techniques have led to the development of multi-modality magnetic resonance, radionuclide, and fluorescence imaging agents for molecular imaging. Herein we discuss advances in dendrimer-based contrast agents for molecular imaging focusing mainly on the chemical design as applied to optical, magnetic resonance, computer tomography, radionuclide, and multi-modality imaging.
引用
收藏
页码:1180 / 1186
页数:7
相关论文
共 28 条
[1]   RATIONALE AND APPLICATIONS FOR MACROMOLECULAR GD-BASED CONTRAST AGENTS [J].
BRASCH, RC .
MAGNETIC RESONANCE IN MEDICINE, 1991, 22 (02) :282-287
[2]  
Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO
[3]  
2-J
[4]   Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].
Caravan, P ;
Ellison, JJ ;
McMurry, TJ ;
Lauffer, RB .
CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352
[5]   Designing new MRI contrast agents: a coordination chemistry challenge [J].
Comblin, V ;
Gilsoul, D ;
Hermann, M ;
Humblet, V ;
Jacques, V ;
Mesbahi, M ;
Sauvage, C ;
Desreux, JF .
COORDINATION CHEMISTRY REVIEWS, 1999, 185-6 :451-470
[6]   Macromolecular contrast agents for MR mammography: current status [J].
Daldrup-Link, HE ;
Brasch, RC .
EUROPEAN RADIOLOGY, 2003, 13 (02) :354-365
[7]   Dendrimer-enhanced MRI as a diagnostic and prognostic biomarker of sepsis-induced acute renal failure in aged mice [J].
Dear, JW ;
Kobayashi, H ;
Jo, SK ;
Holly, MK ;
Hu, XZ ;
Yuen, PST ;
Brechbiel, MW ;
Star, RA .
KIDNEY INTERNATIONAL, 2005, 67 (06) :2159-2167
[8]   Dendritic iodinated contrast agents with PEG-cores for CT imaging: Synthesis and preliminary characterization [J].
Fu, Yanjun ;
Nitecki, Danute E. ;
Maltby, David ;
Simon, Gerhard H. ;
Berejnoi, Kirill ;
Raatschen, Hans-Juergen ;
Yeh, Benjamin M. ;
Shames, David M. ;
Brasch, Robert C. .
BIOCONJUGATE CHEMISTRY, 2006, 17 (04) :1043-1056
[9]   Molecular imaging: The vision and opportunity for radiology in the future [J].
Hoffman, John M. ;
Gambhir, Sanjiv S. .
RADIOLOGY, 2007, 244 (01) :39-47
[10]   Nano-sized MRI contrast agents with dendrimer cores [J].
Kobayashi, H ;
Brechbiel, MW .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (15) :2271-2286